Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

NCT03964012 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis

Interventions

BIOLOGICAL: NmCV-5
BIOLOGICAL: Menactra

Sponsor

Serum Institute of India Pvt. Ltd.

Collaborators

[object Object]